NCT02955173View on ClinicalTrials.gov

Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer

NACompletedINTERVENTIONAL
Enrollment

467

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 14, 2020

Study Completion Date

August 3, 2021

Conditions
Circulating Tumor CellsColorectal CancerGastric Cancer
Interventions
PROCEDURE

Surgery

Laparoscopic or open surgery for resection of gastric or rectal cancer

Trial Locations (1)

250012

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
collaborator

Peking University People's Hospital

OTHER

lead

Qilu Hospital of Shandong University

OTHER

NCT02955173 - Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer | Biotech Hunter | Biotech Hunter